Free tool
Oncology stocks
We cover 7 companies grouped under the Oncology theme. The median market value in the group is $312.81M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −34.9% to +227.3% across the middle 80 percent of the group, with a median of −25.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
7 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +8.36% |
| 4587.T | PeptiDream Inc. | $891.51M | Small cap | −27.31% |
| CU6.AX | Clarity Pharmaceuticals Ltd | $628.73M | Small cap | −25.63% |
| RAC.AX | Racura Oncology Ltd | $312.81M | Small cap | +87.39% |
| SPL.AX | Starpharma Holdings Limited | $248.56M | Small cap | +437.04% |
| 4889.T | Renascience Inc. | $112.48M | Small cap | −40.80% |
| 4575.T | CanBas Co., Ltd. | $103.86M | Small cap | −30.98% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.